An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
about
Remodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis.G protein-coupled receptor kinase 2: a link between myocardial contractile function and cardiac metabolismOptimization of cardiac metabolism in heart failureAdvanced tracers in PET imaging of cardiovascular diseasePET-CMR in heart failure - synergistic or redundant imaging?Radionuclide imaging of myocardial metabolismImaging and modeling of myocardial metabolismTranslation of myocardial metabolic imaging concepts into the clinics.Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy.Impairment of cardiac metabolism and sympathetic innervation after aneurysmal subarachnoid hemorrhage: a nuclear medicine imaging study.Reduced cardiac fructose 2,6 bisphosphate increases hypertrophy and decreases glycolysis following aortic constrictionSynthesis and evaluation of 15-(4-(2-[¹⁸F]Fluoroethoxy)phenyl)pentadecanoic acid: a potential PET tracer for studying myocardial fatty acid metabolism.Longitudinal Evaluation of Fatty Acid Metabolism in Normal and Spontaneously Hypertensive Rat Hearts with Dynamic MicroSPECT Imaging.Modulating fatty acid oxidation in heart failure.Glucose metabolism and cardiac hypertrophyPersistent overexpression of phosphoglycerate mutase, a glycolytic enzyme, modifies energy metabolism and reduces stress resistance of heart in miceCardiac failure in C5-deficient A/J mice after Candida albicans infectionG protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia.Cardiovascular remodelling in coronary artery disease and heart failure.Noninvasive measurement of cardiovascular function in mice with high-temporal-resolution small-animal PETHyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease.Pre-clinical myocardial metabolic alterations in chronic kidney disease.Bariatric surgery to unload the stressed heart: a metabolic hypothesisSevere pulmonary hypertension is associated with altered right ventricle metabolic substrate uptakeHyperpolarized (13)C magnetic resonance reveals early- and late-onset changes to in vivo pyruvate metabolism in the failing heart.A "PET" area of interest: myocardial metabolism in human systolic heart failure.The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action.Adrenergic receptors and metabolism: role in development of cardiovascular diseaseMetabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion.Substrate utilization by the failing human heart by direct quantification using arterio-venous blood sampling.Longitudinal evaluation of left ventricular substrate metabolism, perfusion, and dysfunction in the spontaneously hypertensive rat model of hypertrophy using small-animal PET/CT imagingTaxonomy of segmental myocardial systolic dysfunction.Energetics and metabolism in the failing heart: important but poorly understood.Myocardial energetics in left ventricular hypertrophyMetabolic remodeling in chronic heart failure.In vitro cellular uptake and dimerization of signal transducer and activator of transcription-3 (STAT3) identify the photosensitizing and imaging-potential of isomeric photosensitizers derived from chlorophyll-a and bacteriochlorophyll-a.Imaging of myocardial fatty acid oxidation.The Modulating Effects of Cardiac Resynchronization Therapy on Myocardial Metabolism in Heart Failure.Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.Longitudinal Evaluation of Myocardial Fatty Acid and Glucose Metabolism in Fasted and Nonfasted Spontaneously Hypertensive Rats Using MicroPET/CT.
P2860
Q26853332-C0708885-628F-4B90-8403-18C37566100CQ27014769-04C5457F-6298-48DE-9DE3-D35B67A9BC23Q27023021-20BA7C88-D824-4D3E-BCAF-F65EBF59D4ABQ27023690-03B09285-9412-413A-82B3-5AD3CF12BC3DQ33844251-52F18817-3F32-48F4-9A27-40F70C656E05Q33943594-FA4B3A2E-A434-4F0C-84F3-2571A79B11F4Q33970067-0F5CC376-934F-4608-A336-342B48376D9DQ34089975-FF586783-843E-4C57-9544-5A3F0F5B4995Q34361776-4993AB35-C9C7-43E0-919C-0532C2B579FEQ34501417-E34A843A-1CD9-4A3A-B071-9798DA06E558Q34545425-F6377CE8-2284-4624-9C4D-D292942AA518Q34700405-2532A60B-2727-42DB-8885-AD60B447FD31Q34769220-728D73F0-632C-4424-AFE4-A3A2100B092EQ34808505-FBF31D80-EC1F-4A8C-BD21-35303CE695B9Q34808553-BAA6C6C8-34F7-4E02-BC3A-4CA321BFF387Q34951279-E24D708A-B9B8-486F-938E-2E6BC6F14932Q34975841-CB42E526-B10B-4150-A023-8B0C09C0480CQ35041039-EC1E097F-19E5-45B2-B3C7-147F2A91F121Q35090566-F8B31048-D9AF-49D8-8720-28D2CED25CE9Q35142231-1A4FAAF2-8665-479D-B0FD-A44A5851501DQ35298233-5F6AAFC2-8C69-4AD8-B642-D7E01AAD7D47Q35460057-5267CDCB-CA7E-4272-81DC-7BFC6E827CCBQ35900971-310E138E-89DD-469B-A679-C5B7FACC5C7FQ36017769-75AD08FF-BE9C-48E0-ADA8-A37AFD43580EQ36540577-21BA4AA7-64AC-4806-A0E8-B6DC100ECC9EQ37086847-810AECB9-5106-4C2B-9E64-B182B385A6F1Q37125933-B3C5EBEF-6CB7-4D9C-9A93-C5CB6DDBAFF4Q37212200-E7005787-0B09-4698-9211-8E42FC17B1AFQ37374980-06AC0179-93F4-4FA0-AF15-EB52DC0D0F9CQ37383063-C577147A-DABA-4F64-ABCD-3EA34ECE3F4EQ37724593-C5B1D361-C8D4-433C-BF2E-79C7E9701857Q37738593-C9994C41-D783-4803-B9A3-A9EDE0D2C0BBQ37746834-A2BDB21C-1189-4FF0-9578-14936B417C87Q37777028-B02E6BA0-F221-4B80-AAAC-2942466FF63FQ38125159-02D954CE-B5C6-4FB3-9F20-6D9E0F8EAE84Q38646915-EFFBCF82-87D5-4B22-99B6-A7A039B13049Q38753602-1275C374-6126-4468-9438-BE433D81A35BQ38997240-3F27789E-6AAF-4298-8CBE-3715195DC86BQ41104002-B71B4861-3888-4AFB-B73E-3C71370A7A59Q41665038-A966B427-C0AC-41B5-91B4-445C4A79EDD8
P2860
An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
An evaluation of myocardial fa ...... with Congestive Heart Failure.
@ast
An evaluation of myocardial fa ...... with Congestive Heart Failure.
@en
type
label
An evaluation of myocardial fa ...... with Congestive Heart Failure.
@ast
An evaluation of myocardial fa ...... with Congestive Heart Failure.
@en
prefLabel
An evaluation of myocardial fa ...... with Congestive Heart Failure.
@ast
An evaluation of myocardial fa ...... with Congestive Heart Failure.
@en
P2093
P1476
An evaluation of myocardial fa ...... with Congestive Heart Failure
@en
P2093
Degrado TR
Nickles RJ
Russell DC
Wallhaus TR
P407
P577
2001-01-01T00:00:00Z